Núria Viñolas - Concepedia

Author

Núria Viñolas

Also Known As

Josep Saumench, N Vinolas, N Viñolas, N. VIÑOLAS, N. Vinolas, N. Viñolas, NURIA VIÑOLAS, Nuria Vinolas, Nuria Viñolas, Nuria Viñolas

232

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Hospital Clínic de Barcelona Universitat de Barcelona Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Institut Català d'Oncologia Hospital Universitario Fundación Jiménez Díaz

About

Núria Viñolas is an author at Hospital Clínic de Barcelona specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	41	2.6K
2	Health Sciences	10	10	452
3	Engineering	2	2	34
4	Public Health	1	1	30
5	Blood Transplantation	1	1	11

Núria Viñolas

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial Mariano Provencio, Ernest Nadal, Amelia Insa, The Lancet Oncology MedicineImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation Oncology	2020	788
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma Aleix Prat, Alejandro Navarro, Laia Paré, Cancer Research	2017	468
Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer Manuel Cobo, Dolores Isla, Bartomeu Massutí, Journal of Clinical Oncology	2007	442
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. Francesc Graus, J Dalmou, R. Reñé, Journal of Clinical Oncology	1997	373
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer Elena Gallardo, Alfons Navarro, Núria Viñolas, Carcinogenesis	2009	342
Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance Emilio Montserrat, Juan Sanchez‐Bisono, Núria Viñolas, British Journal of Haematology	1986	324
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial) Mariano Provencio, Roberto Serna‐Blasco, Ernest Nadal, Journal of Clinical Oncology	2022	322
Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trial E. Verger, Miguel Gil‐Gil, Ricardo Yayá, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyPhase IiRadiation TherapyBrain MetastasesMedicine	2004	210
Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer Rafael Molina, Ramón M. Marrades, Josep M. Augé, American Journal of Respiratory and Critical Care Medicine	2015	184
Prognostic Significance of <i>O</i>6-Methylguanine-DNA Methyltransferase Determined by Promoter Hypermethylation and Immunohistochemical Expression in Anaplastic Gliomas Marta Brell, Avelina Tortosa, E. Verger, Clinical Cancer Research	2005	181

Page 1